Nicholas M. Pajewski, Ph.D. - Publications

Affiliations: 
2008 Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Statistics, Biostatistics Biology, Bioinformatics Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Potok OA, Ix JH, Shlipak MG, D Phil RK, Hawfield AT, Rocco MV, Ambrosius WT, Cho ME, Pajewski NM, Rastogi A, Rifkin DE. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 32682697 DOI: 10.1053/J.Ajkd.2020.05.017  0.306
2020 Kurella Tamura M, Gaussoin SA, Pajewski NM, Chelune GJ, Freedman BI, Gure TR, Haley WE, Killeen AA, Oparil S, Rapp SR, Rifkin DE, Supiano M, Williamson JD, Weiner DE. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial. Journal of the American Society of Nephrology : Jasn. PMID 32591439 DOI: 10.1681/Asn.2020010038  0.304
2019 Dobre M, Pajewski NM, Beddhu S, Chonchol M, Hostetter TH, Li P, Rahman M, Servilla K, Weiner DE, Wright JT, Raphael KL. Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 32163578 DOI: 10.1093/Ndt/Gfz149  0.322
2019 Pajewski NM, Berlowitz DR, Bress AP, Callahan KE, Cheung AK, Fine LJ, Gaussoin SA, Johnson KC, King J, Kitzman DW, Kostis JB, Lerner AJ, Lewis CE, Oparil S, Rahman M, et al. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Journal of the American Geriatrics Society. PMID 31840813 DOI: 10.1111/Jgs.16272  0.325
2019 Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, et al. Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT. Journal of the American Heart Association. 8: e011706. PMID 31307270 DOI: 10.1161/Jaha.118.011706  0.31
2019 Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, et al. Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31256724 DOI: 10.1161/Hypertensionaha.119.13073  0.303
2019 Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, ... ... Pajewski NM, et al. Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11912. PMID 31256717 DOI: 10.1161/Hypertensionaha.119.12907  0.302
2019 Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Pinion M, Rahman M, Simmons DL, Taylor A, et al. Abstract P171: Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability: Systolic Blood Pressure Intervention Trial (SPRINT) Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.P171  0.315
2018 Still CH, Pajewski NM, Chelune GJ, Rapp SR, Sink KM, Wadley VG, Williamson JD, Lerner AJ. The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30517599 DOI: 10.1093/Arclin/Acy094  0.307
2017 Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, et al. Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes. The New England Journal of Medicine. 377: 733-744. PMID 28834483 DOI: 10.1056/Nejmoa1611179  0.328
2017 Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM. APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. Kidney International Reports. 2: 713-720. PMID 28758155 DOI: 10.1016/J.Ekir.2017.03.008  0.319
2017 Odden MC, Peralta CA, Berlowitz DR, Johnson KC, Whittle J, Kitzman DW, Beddhu S, Nord JW, Papademetriou V, Williamson JD, Pajewski NM. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial. Jama Internal Medicine. PMID 28166324 DOI: 10.1001/Jamainternmed.2016.9104  0.332
2017 Pajewski N, Williamson J, Supiano MA. Transitions In Frailty Status In The Systolic Blood Pressure Intervention Trial Innovation in Aging. 1: 265-266. DOI: 10.1093/Geroni/Igx004.973  0.301
2016 Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (Dallas, Tex. : 1979). PMID 27849563 DOI: 10.1161/Hypertensionaha.116.08076  0.31
2016 Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, ... ... Pajewski NM, et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. Jama. PMID 27195814 DOI: 10.1001/Jama.2016.7050  0.34
2016 Pajewski NM, Williamson JD, Applegate WB, Berlowitz DR, Bolin LP, Chertow GM, Krousel-Wood MA, Lopez-Barrera N, Powell JR, Roumie CL, Still C, Sink KM, Tang R, Wright CB, Supiano MA, et al. Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 26755682 DOI: 10.1093/Gerona/Glv228  0.335
2015 Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney International. 87: 169-75. PMID 25029429 DOI: 10.1038/Ki.2014.254  0.331
Show low-probability matches.